Investigating small molecules that mimic GDNF for nerve repair
Mid-sized GDNF Mimics For Neural Regeneration
This study is working on new tiny molecules that can help nerves heal better after injuries by mimicking a natural protein called GDNF, which could lead to improved treatments for people with nerve damage.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10811356 on NIH RePORTER |
What this research studies
This research focuses on developing small molecule mimics of glial cell line-derived neurotrophic factor (GDNF) to enhance nerve regeneration after traumatic injuries. By creating compounds that can effectively interact with GDNF receptors, the project aims to stimulate cellular responses that promote neuronal connectivity. The approach involves designing and testing these mimics to improve their stability and effectiveness compared to existing therapies. Patients may benefit from advancements in treatments for nerve damage through this innovative strategy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced traumatic nerve injuries and are seeking new treatment options.
Not a fit: Patients with non-traumatic nerve conditions or those who do not have nerve injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for nerve injuries, improving recovery outcomes for patients.
How similar studies have performed: While there have been some studies on GDNF and its family ligands, the approach of using small molecule mimics is relatively novel and has not been extensively tested.
Where this research is happening
College Station, United States
- Texas A&m University — College Station, United States (Active)
Researchers
- Principal investigator: Burgess, Kevin — Texas A&m University
- Study coordinator: Burgess, Kevin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.